Informed consent for paediatric clinical trials in Europe

Show full item record



Permalink

http://hdl.handle.net/10138/170154

Citation

Lepola , P , Needham , A , Mendum , J , Sallabank , P , Neubauer , D & de Wildt , S 2016 , ' Informed consent for paediatric clinical trials in Europe ' , Archives of Disease in Childhood , vol. 101 , no. 11 , pp. 1017-1025 . https://doi.org/10.1136/archdischild-2015-310001

Title: Informed consent for paediatric clinical trials in Europe
Author: Lepola, Pirkko; Needham, Allison; Mendum, Jo; Sallabank, Peter; Neubauer, David; de Wildt, Saskia
Other contributor: University of Helsinki, Clinicum
Date: 2016-11
Language: eng
Number of pages: 9
Belongs to series: Archives of Disease in Childhood
ISSN: 0003-9888
DOI: https://doi.org/10.1136/archdischild-2015-310001
URI: http://hdl.handle.net/10138/170154
Abstract: Objective Paediatric clinical trials are often conducted as multinational trials. Informed consent or assent is part of the ethics committee approval for clinical trials. The consent requirements vary between countries due to national laws and regulations, which are not harmonised in Europe. These discrepancies can present challenges for paediatric clinical trials. The aim of this study was to assemble these consent and assent requirements across the European Economic Area. The collated national requirements have not been publicly available before, despite a real need for this data. Methods National consent and assent requirements for paediatric clinical trials were analysed and collated for 25 European Union Member States and 2 European Free Trade Association countries until the end of 2014. The data were retrieved from existing databases and through communication with the competent authorities and selected ethics committees. Results from a literature search for international or national guidelines, declarations and conventions and academic societies' publications served as comparison material. Results Consent and assent requirements are heterogeneous across these countries. We compiled our findings in 'The Informed Consent and Assent Tool Kit', a table including 27 national consent and assent requirements listed by individual country. Conclusions Wide variation in paediatric consents and assents presents challenges for multinational paediatric trials in Europe. The toolkit is available for all those involved in paediatric clinical trials and ethics committees, providing a new platform for proactive feedback on informed consent requirements, and may finally lead to a needed harmonisation process, including uniform standards accepted across Europe.
Subject: ETHICS WORKING GROUP
GUIDELINES
COMMITTEES
POPULATIONS
COUNTRIES
GUIDANCE
CHILDREN
CONDUCT
CESP
3123 Gynaecology and paediatrics
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1017.full.pdf 468.7Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record